Olesoxime accelerates myelination and promotes repair in models of demyelination. (Q48639256)

13 February 2018

title

Olesoxime accelerates myelination and promotes repair in models of demyelination. (English)

1 reference

13 February 2018

1 reference

Karine Magalon

1

1 reference

13 February 2018

Celine Zimmer

2

1 reference

13 February 2018

Myriam Cayre

3

1 reference

13 February 2018

Joseph Khaldi

4

1 reference

13 February 2018

Clarisse Bourbon

5

1 reference

13 February 2018

Isabelle Robles

6

1 reference

13 February 2018

Gwenaëlle Tardif

7

1 reference

13 February 2018

Angèle Viola

8

1 reference

13 February 2018

Rebecca M Pruss

9

1 reference

13 February 2018

Thierry Bordet

10

1 reference

13 February 2018

Pascale Durbec

11

1 reference

13 February 2018

publication date

1 February 2012

1 reference

13 February 2018

published in

Annals of Neurology

1 reference

13 February 2018

volume

71

1 reference

13 February 2018

issue

2

1 reference

13 February 2018

page(s)

213-226

1 reference

13 February 2018

Stem cell transplantation in multiple sclerosis: current status and future prospects

cites work

1 reference

Enhancing central nervous system remyelination in multiple sclerosis

21 January 2018

1 reference

Remyelination in the CNS: from biology to therapy

21 January 2018

1 reference

Regulation of Oligodendrocyte Differentiation and Myelination

21 January 2018

1 reference

Why does remyelination fail in multiple sclerosis?

21 January 2018

1 reference

Myelin regeneration in demyelinating disorders: new developments in biology and clinical pathology

21 January 2018

1 reference

Origin of oligodendrocytes in the subventricular zone of the adult brain.

21 January 2018

1 reference

Chordin-induced lineage plasticity of adult SVZ neuroblasts after demyelination

21 January 2018

1 reference

Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis

21 January 2018

1 reference

Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination

21 January 2018

1 reference

Insulin-like growth factor system regulates oligodendroglial cell behavior: therapeutic potential in CNS.

21 January 2018

1 reference

Oligodendrocyte progenitor proliferation and maturation is differentially regulated by male and female sex steroid hormones

21 January 2018

1 reference

Lovastatin induces the formation of abnormal myelin-like membrane sheets in primary oligodendrocytes

21 January 2018

1 reference

Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis

21 January 2018

1 reference

Growth factor treatment promotes mobilization of young but not aged adult subventricular zone precursors in response to demyelination.

21 January 2018

1 reference

Intranasal HB-EGF administration favors adult SVZ cell mobilization to demyelinated lesions in mouse corpus callosum

21 January 2018

1 reference

Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells

21 January 2018

1 reference

Isolation and culture of rat and mouse oligodendrocyte precursor cells.

21 January 2018

1 reference

Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation.

21 January 2018

1 reference

Identification of dystroglycan as a second laminin receptor in oligodendrocytes, with a role in myelination

21 January 2018

1 reference

Enriched environment promotes adult neural progenitor cell mobilization in mouse demyelination models.

21 January 2018

1 reference

Block of neural Kv1.1 potassium channels for neuroinflammatory disease therapy.

21 January 2018

1 reference

Interactions between oligodendrocyte precursors control the onset of CNS myelination

21 January 2018

1 reference

PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice.

21 January 2018

1 reference

Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice

21 January 2018

1 reference

Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination.

21 January 2018

1 reference

Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination

21 January 2018

1 reference

The mitochondrial permeability transition pore regulates nitric oxide-mediated apoptosis of neurons induced by target deprivation

21 January 2018

1 reference

Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound

21 January 2018

1 reference

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

21 January 2018

1 reference

Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis

21 January 2018

1 reference

Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cells.

21 January 2018

1 reference

Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating alpha-tubulin

21 January 2018

1 reference

Microtubule deacetylases, SirT2 and HDAC6, in the nervous system

21 January 2018

1 reference

Role of the oligodendroglial cytoskeleton in differentiation and myelination

21 January 2018

1 reference

Tubulin polymerization-promoting protein (TPPP/p25) is critical for oligodendrocyte differentiation

21 January 2018

1 reference

Multiple sclerosis: an immune or neurodegenerative disorder?

21 January 2018

1 reference

Secondary progressive multiple sclerosis: current knowledge and future challenges

21 January 2018

1 reference

LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.22593

1 reference

13 February 2018

PubMed ID

22367994

1 reference

13 February 2018